Advancing Women Artists Foundation

New to The Street Announces Six Business Interviews on its 524th Show, Airing on the Fox Business Network, Monday, October 23, 2023, at 10:30 PM PT

Retrieved on: 
Friday, October 20, 2023

New to The Street's 524th TV episode line-up features the following six (6) business interviews:

Key Points: 
  • New to The Street's 524th TV episode line-up features the following six (6) business interviews:
    1).
  • Pet Health – PetVivo Holdings, Inc.'s (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV) interview with John Lai, CEO/President.
  • Space Travel Medicines - Vector Space Biosciences, Inc.'s ( SBIO ) interview with Kasian Franks, CEO and Co-Founder.
  • Management expects to move forward with Phase 3 clinical trials with the expectation of an FDA approval in 2026.

Aspivix receives U.S. FDA 510(k) clearance for Carevix™, its novel cervical stabilizer

Retrieved on: 
Thursday, February 2, 2023

LAUSANNE, Switzerland, Feb. 2, 2023 /PRNewswire/ -- ASPIVIX SA, an innovator and developer of medical technologies to advance gynecological care, today announced that Carevix™, its novel Cervical Stabilizer, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Key Points: 
  • LAUSANNE, Switzerland, Feb. 2, 2023 /PRNewswire/ -- ASPIVIX SA, an innovator and developer of medical technologies to advance gynecological care, today announced that Carevix™, its novel Cervical Stabilizer, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
  • This next generation device for routine procedures in gynecology will allow millions of women across the USA access to significantly less painful treatments and IUD insertions
    Carevix™ is an atraumatic cervical stabilizer that utilizes a gentle approach to reduce pain and bleeding in multiple transcervical procedures, such as, Intrauterine Device insertions.
  • Mathieu Horras, Chief Executive Officer of ASPIVIX emphasized: "With the 510(k) clearance of Carevix™, a design-award winning device, we will provide our U.S. customers with an innovative and easy-to-use system that brings a gentler alternative to a century-old gynecological tool.
  • Extensive research was incorporated into the development of Carevix™ so we know the unique and differentiating features it demonstrates with significant less pain and bleeding that has the potential to dramatically improve the IUD adoption and placement experience for millions of American women."

Aspivix receives U.S. FDA 510(k) clearance for Carevix™, its novel cervical stabilizer

Retrieved on: 
Thursday, February 2, 2023

LAUSANNE, Switzerland, Feb. 2, 2023 /PRNewswire/ -- ASPIVIX SA, an innovator and developer of medical technologies to advance gynecological care, today announced that Carevix™, its novel Cervical Stabilizer, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Key Points: 
  • LAUSANNE, Switzerland, Feb. 2, 2023 /PRNewswire/ -- ASPIVIX SA, an innovator and developer of medical technologies to advance gynecological care, today announced that Carevix™, its novel Cervical Stabilizer, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
  • This next generation device for routine procedures in gynecology will allow millions of women across the USA access to significantly less painful treatments and IUD insertions.
  • Carevix™ is an atraumatic cervical stabilizer that utilizes a gentle approach to reduce pain and bleeding in multiple transcervical procedures, such as, Intrauterine Device insertions.
  • Mathieu Horras, Chief Executive Officer of ASPIVIX emphasized: "With the 510(k) clearance of Carevix™, a design-award winning device, we will provide our U.S. customers with an innovative and easy-to-use system that brings a gentler alternative to a century-old gynecological tool.

Art Entrepreneur Andy Valmorbida Launches River-Labs, New Tech Platform Introducing Real Art Assets on Blockchain Bridging Physical & Digital Fine Art

Retrieved on: 
Thursday, August 18, 2022

NEW YORK, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Renowned international art pioneer Andy Valmorbida announced the launch of River-Labs , a groundbreaking Web3 digital marketplace offering handcrafted generative digital art from emerging and established artists.

Key Points: 
  • NEW YORK, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Renowned international art pioneer Andy Valmorbida announced the launch of River-Labs , a groundbreaking Web3 digital marketplace offering handcrafted generative digital art from emerging and established artists.
  • "Digital art on the blockchain is more than just art; it is 'life meets art.'
  • Australian-born and American-raised, Andy Valmorbida is an art entrepreneur, collector, and pioneer of the "pop-up" gallery model, who has also been instrumental in popularizing street art over two decades.
  • River-Labs is a digital marketplace harboring art history and curating cultural programs for collective ecospheres rooted in contemporary and urban art.

clinical data show significantly lower iud procedural pain and bleeding rates with aspivix's novel SUCTION-BASED CERVICAL Device

Retrieved on: 
Wednesday, May 25, 2022

Pain scores were 52% lower with the Carevix device during cervix grasping, 53% lower during cervix stabilization (traction), 30% lower during IUD insertion, and 33% lower during cervix release, compared to tenaculum use.

Key Points: 
  • Pain scores were 52% lower with the Carevix device during cervix grasping, 53% lower during cervix stabilization (traction), 30% lower during IUD insertion, and 33% lower during cervix release, compared to tenaculum use.
  • During IUD insertion, twice as many nulliparouswomenin the Carevix group were free of pain compared to those in the tenaculum group, and they reported an 88% lower rate of severe pain.
  • Carevixis an innovative, soft-suction cervical device designed as a modern and gentler alternative to a cervical tenaculum when stabilization of the cervix is needed.
  • A semi-circular, anatomical pad is applied onto the delicate tissue during gynecological procedures, reducing trauma associated with pain and bleeding.

CLINICAL DATA SHOW SIGNIFICANTLY LOWER IUD PROCEDURAL PAIN AND BLEEDING RATES WITH ASPIVIX'S NOVEL SUCTION-BASED CERVICAL DEVICE

Retrieved on: 
Wednesday, May 25, 2022

Pain scores were 52% lower with the Carevix device during cervix grasping, 53% lower during cervix stabilization (traction), 30% lower during IUD insertion, and 33% lower during cervix release, compared to tenaculum use.

Key Points: 
  • Pain scores were 52% lower with the Carevix device during cervix grasping, 53% lower during cervix stabilization (traction), 30% lower during IUD insertion, and 33% lower during cervix release, compared to tenaculum use.
  • During IUD insertion, twice as many nulliparouswomenin the Carevix group were free of pain compared to those in the tenaculum group, and they reported an 88% lower rate of severe pain.
  • Carevixis an innovative, soft-suction cervical device designed as a modern and gentler alternative to a cervical tenaculum when stabilization of the cervix is needed.
  • A semi-circular, anatomical pad is applied onto the delicate tissue during gynecological procedures, reducing trauma associated with pain and bleeding.

Getting Hired Expands Diversity and Inclusion Talent Platform and Launches Direct Talent Sourcing Initiative

Retrieved on: 
Tuesday, April 19, 2022

HANOVER, Md., April 19, 2022 /PRNewswire/ -- Getting Hired , Inc., an Allegis Group company, announces the expansion of its talent engagement platform to engage and serve additional underrepresented groups in the workforce, and the launch of Diversity Talent Sourcing, a new direct sourcing offering.

Key Points: 
  • HANOVER, Md., April 19, 2022 /PRNewswire/ -- Getting Hired , Inc., an Allegis Group company, announces the expansion of its talent engagement platform to engage and serve additional underrepresented groups in the workforce, and the launch of Diversity Talent Sourcing, a new direct sourcing offering.
  • Both initiatives align with Getting Hired's mission of breaking down barriers within talent acquisition for job seekers and employers.
  • Getting Hired's virtual communities now expand beyond Individuals with Disabilities to also include Veterans and BIPOC (Black, Indigenous, People of Color).
  • Getting Hired's Diversity Talent Sourcing offering leverages the platform's access to multiple historically underrepresented talent groups and amplifies its impact and reach through the artificial intelligence capabilities of QuantumWork , our cloud-based intelligent sourcing platform.

RtistiQ Set To Launch Digital NFTs of Raja Ravi Varma's 'The Coquette' and 'Reclining Nair Lady'

Retrieved on: 
Wednesday, February 9, 2022

NEW YORK, Feb. 9, 2022 /PRNewswire/ -- To start off the new year, RtistiQ will present the Digital NFT versions of Raja Ravi Varma's (RRV) works The Coquette and Reclining Nair Lady, two of his most famous paintings. With the originals considered to be National Treasures and unable to be brought out of India, the NFT versions will be auctioned online on the RtistiQ platform from 17 February to 20 February 2022.

Key Points: 
  • Considered to be national treasures, this collection of works of Raja Ravi Varma will be the first-ever to be tokenized and launched, accepting payments via credit card and crypto.
  • Raja Ravi Varma was an Indian painter and artist and is considered to be among the greatest painters in the history of Indian art.
  • RtistiQ is a distinct physical and digital art marketplace that brings together artworks created by artists from over 38 countries.
  • Raja Ravi Varma Heritage Foundation is a not-for-profit institution that works to preserve and promote the artistic legacy of one of India's greatest artists.